Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

'Split' buys from 2-for-1


Bookmark and Share

 By purchasing only stocks that have made stock split announcements, Neal Macneale has seen the portfolio in his 2-for-1 newsletter return almost three times the S&P 500 for the past 12 years,with its 7.8% annualized return.

With no new stock splits announced over the past month, the advisor has reviewed his current holdings and reviews four that he feels are particularly timely for new purchase.

"There were no split announcements in October so there won’t be a new buy recommendation for a new position in the 2 for 1 portfolio.

Advertisement
Banner

"This is unfortunate because now is the time to be buying. There are some terrific bargains in stocks right now. Here are a few ideas for your consideration from among our previous purchases.

"Many of the stocks already in the portfolio are now selling at fire-sale prices. I also looked over all the splits announced over the last year and there are companies, not picked for 2 for 1 at the time, that now are very attractive.

"Of all 30 stocks in the portfolio, plus an additional twelve splits announced over the last year, there are four that especially deserve your attention. I would buy any or all of them depending on your situation. I don’t list them in any particular order.

"Graham Corp. (NYSE: GHM) was bought for the portfolio in August and has been absolutely hammered since then. It now sells at its Jan. ’06 level for only twice its book value. It has no debt, and it is in a business that is not going away.

"Integral Systems (NASDAQ: ISYS) was my September buy and has \dropped only slightly since then. I recommend it again because of its very strong balance sheet and its recession proof business.

"Rofin-Sinar Technologies (NASDAQ: RSTI) makes all sorts of industrial and medical lasers. It split last January and is now selling for less than half its price at the time of the split.

"Robins & Meyers (NYSE: RBN) makes industrial equipment used in oil well drilling, pharmaceutical processing, and food and drug packaging.

"Both Rofin-Sinar and Robins & Myers have exceptionally strong balance sheets and should plow right through any recession.

"I emphasize again; if you have cash or are reallocating out of other asset classes, now is the time to buy, and these four stocks would all be good candidates for current purchases."


Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary